Merck CEO Ken Frazier Named to the TIME Top 100, Fortune Top 50 Lists
Ken Frazier’s career has advanced the march of progress. His leadership both inside and outside of Merck has earned him a spot on both TIME Magazine’s and Fortune Magazine’s Top Lists this week.
TIME Magazine has named Ken Frazier, Merck chairman and CEO, to the 2018 TIME 100, its annual list of the 100 most influential people in the world. The list, now in its fifteenth year, recognizes the activism, innovation and achievement of the world’s most influential individuals. You can read TIME’s perspective written by Vernon Jordan here: http://time.com/collection/most-influential-people-2018/5217616/kenneth-c-frazier/.
Ken was also honored this week by being named to the #5 spot on Fortune’s World’s Greatest 50 Leaders list. Read more: http://fortune.com/longform/worlds-greatest-leaders-2018/#ken.
About Merck
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
